According to filings with the U.S. Securities and Exchange Commission, Kanvas Biosciences is raising up to $10,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Matthew Cheng played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Kanvas Biosciences
We are a young startup building new tools and methods to image microbes and describe their environments. Our full-stack tech­nol­o­gy plat­form brings micro­bio­me drug dis­cov­ery into focus. Our spa­tial map­ping dis­cov­ery engine pro­vides stun­ning pic­tures of the inter­ac­tions and con­nec­tions between host and the micro­bio­me; an area of this vital sys­tem that we’ve nev­er been able to com­plete­ly under­stand before. Spa­tial biol­o­gy of the host-micro­bio­me inter­face pro­vides new oppor­tu­ni­ties for effec­tive ther­a­peu­tic inter­ven­tions, ulti­mate­ly enabling us to bet­ter treat patients. There are over 10³⁰ bac­te­ria on Earth, and these microor­gan­isms are insep­a­ra­ble from the lives of all liv­ing things on the plan­et. Our mis­sion at Kan­vas is to illu­mi­nate micro­bial life with advanced imag­ing tools and trans­late unique insights to cre­ate nov­el micro­bial therapeutics.

To learn more about Kanvas Biosciences, visit http://kanvasbio.com/

Contact:
Matthew Cheng, Chief Executive Officer
617-435-4900

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.